Chawnshang Chang

Also affiliated with University of Rochester Medicine, China Medical University Hospital

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Androgen receptor‐regulated circFNTA activates KRAS signaling to promote bladder cancer invasion”.

Androgen receptor‐regulated circFNTA activates KRAS signaling to promote bladder cancer invasion

EMBO Reports(2020)10.15252/embr.201948467

N/A

2.6DataRank · unranked

94 citations

Yin Sun, Zhenyu Ou, Shuyuan Yeh, Chi‐Ping Huang, Bosen You +5 more

The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling

Cell Death and Differentiation(2020)10.1038/s41418-020-0575-3

N/A

0DataRank · unranked

82 citations

Xiwu Ouyang, Yin Sun, Yao Xiao, Bosen You, Yuan Gao +4 more

Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer

Cell Death and Disease(2020)10.1038/s41419-020-02970-4

N/A

0DataRank · unranked

14 citations

Chang-Yi Lin, Hao Tian, Wan-Ying Lin, Bosen You, Jieyang Lu +7 more

The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer

Cell Death and Disease(2020)10.1038/s41419-020-02932-w

N/A

0DataRank · unranked

35 citations

Yin Sun, Min Tang, Chao Liang, Chi‐Ping Huang, Yuanjie Niu +3 more

Androgen Receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.30.180067

N/A

0DataRank · unranked

1 citations

Yin Sun, Qing Liu, Keliang Wang, Ruizhe Fang, Bingmei Liu +9 more

Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR

Oncogene(2021)10.1038/s41388-020-01616-1

N/A

0DataRank · unranked

63 citations

Yin Sun, Jie Luo, Keliang Wang, Qing Liu, Ruizhe Fang +9 more

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals

Cell Death and Differentiation(2021)10.1038/s41418-021-00743-w

N/A

0DataRank · unranked

60 citations

Ronghao Wang, Yin Sun, Chi‐Ping Huang, Shuyuan Yeh, Bosen You +5 more

Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death

Cell Death and Disease(2021)10.1038/s41419-020-03321-z

N/A

0DataRank · unranked

14 citations

Yin Sun, Bosen You, Meng Zhang, Chi‐Ping Huang, Junfeng Yu +4 more

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis

Cell Death and Disease(2022)10.1038/s41419-022-04979-3

N/A

0DataRank · unranked

67 citations

Jindong Sheng, Shuai Hu, Yun Cui, Jing Xiao, Wei Yu +11 more

Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis

Cell & Bioscience(2022)10.1186/s13578-022-00912-5

N/A

0DataRank · unranked

12 citations

Yin Sun, Wei Zhai, Xudong Yao, Dongkui Gong, Bosen You +4 more

Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis

Research Square(2022)10.21203/rs.3.rs-1632568/v1

N/A

0DataRank · unranked

2 citations

Yin Sun, Wei Zhai, Xudong Yao, Dongkui Gong, Bosen You +4 more